Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

Clinical trial NCT02311101 · COMPLETED

Trial details

NCT number: NCT02311101
Sponsor: The University of Texas Health Science Center at San Antonio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Urinary Bladder Neoplasm

Start date: 2012-03-01
Primary completion: 2015-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.